New Article Published: Nerofe Phase I trial summaryDecember 11, 2017
The Phase I Nerofe (dTCApFs) human trial summary has been published in the Molecular and Clinical Oncology Journal.
In this trial Nerofe was found to be safe and well‑tolerated, and potentially efficacious as an anti-cancer agent.
